HCLS chartering/next steps Thur 26 May

Hi all, as some of you reallize, the charter ends at the end of this
month. I've been polling around to see what alternative formulations
would give us the most resources and impact. In the process, I wrote
up some of our high-level use cases (elevator speeches) to help us
approach the relevant parties in pharmas, health services and
research: <http://www.w3.org/2011/05/HCLSIGUseCases>.

I'd like to discuss the landscape and potential strategies with the
community. I'd particularly like to invite those who have been active
or see themselves as being active in the next incarnation of the group.
We'll discuss the current, fairly conservative draft charter
<http://www.w3.org/2011/05/HCLSIGCharter-proposal>, as well as ways to
optimize both its message and the paths for dissemination. An example
of a messaging alternative would be to characterize the HCLS IG work
in terms of e.g. overarching translational medicine use cases:
"
  The W3C Semantic Web in Health Care and Life Sciences Interest Group
  focuses on translational medicine use cases. The group will continue
  the aggregation of cutting edge and traditional scientific knowledge
  to meet use cases for researchers, care givers, patients and
  regulatory agencies. Due to the scope and diversity of expertise
  required to meet translational needs, the HCLS IG work is broken
  down into discrete task forces focused on particular data
  acquisition, modeling and integration requirements:

  Terminology - identifying and integrating identifiers for biological
  processes, gross anatomy and medical procedures to promote
  unification of domain data.

  LODD - curation of compounds, clinical trials and outcomes.

  BioRDF - modeling of biological processes and actors.

  Scientific Discourse - representation and tracking of the changing
  landscape of scientific knowledge and the driving theora and
  experiments.

  Translational Medicine - the oversight and high-level ontology that
  connects these disciplines together in order to meet immediate and
  long term needs from pharma, health care and other vested parties.
"
. Perhaps you all have some other ideas about how to tell a story
about our work which will serve to both draw people to our work and
our products and to help already interested parties find the task
forces which interest them. I of course want to draw an optimal
balance between doing work which motivates the participants and
focusing on tasks which will accelerate education and adoption by
important organizations.

I'm sure you are all aware of my preference for technical work, but I
feel that this outreach can make us all ultimately more effective. I
will use the Thursday 26 May HCLS slot (11:00 EDT) to reach out to the
current HCLS IG community, and whomever else you folks elect to bring
along. Of course, I'll reserve extra teleconference slots, but please
RSVP to me privately so I can make a guess at how many ports to
reserve. Also, please provide what feedback you can before the
conference. Anything we take care of before will make the meeting more
efficient.

Conference Details

Date of Call: Thursday, May 26, 2011
Time of Call: 11:00 am Eastern Time, 4 pm UK, 5 pm CET
Dial-In #: +1.617.761.6200 (Cambridge, MA)
[Note: limited access to European dial in numbers below]
Dial-In #: +33.4.26.46.79.03 (Nice, France)
Dial-In #: +44.203.318.0479 (Bristol, UK)
Participant Access Code: 4257 ("HCLS")
IRC Channel: irc.w3.org port 6665 channel #HCLS (see W3C IRC page for
details, or see Web IRC), Quick Start: Use
http://www.mibbit.com/chat/?server=irc.w3.org:6665&channel=%23hcls for
IRC access.
Duration: ~1 hour
Convener: Eric Prud'hommeaux
Scribe: TBD

HCLS IG charter/strategy discussion
-- 
-ericP

Received on Tuesday, 24 May 2011 03:05:07 UTC